BioSig’s PURE EP™ System Highlighted in the Journal of Atrial Fibrillation & Electrophysiology December 6, 2022
BioSig Signs Master Research Agreement with Cleveland Clinic to Explore Expanded Applications for its Digital Signal Processing Technology October 24, 2022
BioSig Executes Purchase Agreement with Methodist Hospital, San Antonio and Expands Customer Base October 7, 2022
BioSig Strengthens Marketing and Sales Teams, Appoints National Account Executives to Scale Commercial Growth August 30, 2022
BioSig Places Second PURE EP™ System For Evaluation at Cleveland Clinic a Leading Medical Center of Excellence August 24, 2022
BioSig’s Cardiac Signal Processing Technology To Be Featured at Kansas City Heart Rhythm Symposium 2022 August 17, 2022
BioSig Announces Physician-Initiated Research Protocol at The Kansas City Heart Rhythm Institute July 21, 2022
